CHME

China Medicine (CE) (CHME)

China Medicine Corporation (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CHME

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2015/02/18	05 : 30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CHME	China Medicine Corporation (CE)
2014/02/18	22 : 06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CHME	China Medicine Corporation (CE)
2013/03/27	13 : 00	OTC Markets	Tier Change	USOTC:CHME	China Medicine Corporation (CE)
2013/02/23	02 : 25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CHME	China Medicine Corporation (CE)
2013/01/08	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:CHME	China Medicine Corporation (CE)
2013/01/08	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:CHME	China Medicine Corporation (CE)
2013/01/08	07 : 18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)	USOTC:CHME	China Medicine Corporation (CE)
2013/01/08	07 : 18	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 13 and 15(d) (15-15D)	USOTC:CHME	China Medicine Corporation (CE)
2012/12/22	06 : 08	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:CHME	China Medicine Corporation (CE)
2012/12/22	06 : 08	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CHME	China Medicine Corporation (CE)
2012/12/22	06 : 07	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:CHME	China Medicine Corporation (CE)
2012/12/22	06 : 07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:CHME	China Medicine Corporation (CE)
2012/12/22	06 : 07	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/28	05 : 11	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/19	03 : 24	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/19	03 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/14	06 : 20	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/08	03 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2012/09/08	03 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2012/08/04	06 : 03	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:CHME	China Medicine Corporation (CE)
2012/04/03	05 : 11	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:CHME	China Medicine Corporation (CE)
2012/02/15	20 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:CHME	China Medicine Corporation (CE)
2011/11/16	02 : 17	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:CHME	China Medicine Corporation (CE)
2011/09/28	06 : 03	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:CHME	China Medicine Corporation (CE)
2011/08/23	06 : 03	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:CHME	China Medicine Corporation (CE)
2011/08/17	04 : 30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2011/08/17	00 : 02	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:CHME	China Medicine Corporation (CE)
2011/08/12	10 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2011/08/12	10 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CHME	China Medicine Corporation (CE)
2011/07/21	06 : 19	Marketwired	Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against China Medicine Corporation (OTCBB: C	USOTC:CHME	China Medicine Corporation (CE)